The Europe Epigenetics Market would witness market growth of 14.1% CAGR during the forecast period (2022-2028).
The Epidemiology and Genomics Research Program (EGRP) provides funding for research-related activities. The growing need for personalization in healthcare due to genetic variations, expanding application in non-oncology diseases, and target therapy is expected to provide market players with growth opportunities in the coming years. Additionally, private institutions are sponsoring, R&D projects and biopharmaceutical businesses are driving the market growth for the detection of a biomarker for medication development and disease. Furthermore, the growing geriatric population in various parts of the world is likely to support the expanding industry. However, the instruments' high initial and ongoing costs prove to be a substantial impediment to commercial expansion. The epigenetics market faces significant hurdles, such as a dearth of skilled specialists and worries about the quality of antibodies.
In addition, the market is driven by an increase in cancer, infectious diseases, and genetic abnormalities. Drugs created via extensive epigenetic research effectively treat a specific form of cancer, lowering treatment costs and allowing treatment to be delivered at affordable prices in developing and underdeveloped countries. When compared to standard cancer treatments, epigenetics offers targeted therapeutic actions that target only the host's damaged and malignant cells.
One of the key trends in the regional market is the growing geriatric population. In this region, R&D projects connected to the investigation of epigenetic bases in various diseases are on the rise. The EpiGen Research Consortium, located in the United Kingdom, has expanded its studies facility in Singapore for chronic disease research, including diabetes and obesity.
Some of the growth catalysts for the market the rising incidence and frequency of cancer, increased investment for R&D in healthcare, and rising epigenetic applications in non-oncology disorders. According to the World Health Organization, cancer causes more than 3.7 million new cases and 1.9 million deaths each year, making it the second leading cause of death and illness in the European region.
The market for cancer genetics has seen a golden period in recent years. The cost of gene sequencing has come down to the point where researchers can analyze the genomes of tens of thousands of patients, comparing the DNA of diseased and healthy tissues to uncover mutations linked to tumor formation and growth, which is linked to cancer. Epigenetic advancements are quietly constructing a toolbox for strong cancer-fighting medications. Therefore, these aspects are expected to accelerate the growth of the Epigenetics Market over the forecast years.
The Germany market dominated the Europe Epigenetics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $185.4 Million by 2028. The UK market is experiencing a CAGR of 13.2% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 14.9% during (2022 - 2028).
Based on Application, the market is segmented into Oncology and Non-Oncology. Based on Product, the market is segmented into Kits, Reagents, Enzymes, and Instruments. Based on End User , the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Contract Research Organizations. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Epigenetics Market Size will Hit $2.9 Billion by 2028, at a CAGR of 14.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abcam plc, Agilent Technologies, Inc., Hologic, Inc., Illumina, Inc., Merck Group, PerkinElmer, Inc., Qiagen N.V., Thermo Fisher Scientific, Inc., Zymo Research, and Active Motif, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Application
By Product
- Kits
- Reagents
- Enzymes
- Instruments
By End User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Abcam plc
- Agilent Technologies, Inc.
- Hologic, Inc.
- Illumina, Inc.
- Merck Group
- PerkinElmer, Inc.
- Qiagen N.V.
- Thermo Fisher Scientific, Inc.
- Zymo Research
- Active Motif, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Epigenetics Market, by Application
1.4.2 Europe Epigenetics Market, by Product
1.4.3 Europe Epigenetics Market, by End User
1.4.4 Europe Epigenetics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2018, Apr – 2021, Dec) Leading Players
Chapter 4. Europe Epigenetics Market by Application
4.1 Europe Oncology Market by Country
4.2 Europe Non Oncology Market by Country
Chapter 5. Europe Epigenetics Market by Product
5.1 Europe Kits Market by Country
5.2 Europe Reagents Market by Country
5.3 Europe Enzymes Market by Country
5.4 Europe Instruments Market by Country
Chapter 6. Europe Epigenetics Market by End User
6.1 Europe Pharmaceutical & Biotechnology Companies Market by Country
6.2 Europe Academic & Research Institutes Market by Country
6.3 Europe Contract Research Organizations Market by Country
Chapter 7. Europe Epigenetics Market by Country
7.1 Germany Epigenetics Market
7.1.1 Germany Epigenetics Market by Application
7.1.2 Germany Epigenetics Market by Product
7.1.3 Germany Epigenetics Market by End User
7.2 UK Epigenetics Market
7.2.1 UK Epigenetics Market by Application
7.2.2 UK Epigenetics Market by Product
7.2.3 UK Epigenetics Market by End User
7.3 France Epigenetics Market
7.3.1 France Epigenetics Market by Application
7.3.2 France Epigenetics Market by Product
7.3.3 France Epigenetics Market by End User
7.4 Russia Epigenetics Market
7.4.1 Russia Epigenetics Market by Application
7.4.2 Russia Epigenetics Market by Product
7.4.3 Russia Epigenetics Market by End User
7.5 Spain Epigenetics Market
7.5.1 Spain Epigenetics Market by Application
7.5.2 Spain Epigenetics Market by Product
7.5.3 Spain Epigenetics Market by End User
7.6 Italy Epigenetics Market
7.6.1 Italy Epigenetics Market by Application
7.6.2 Italy Epigenetics Market by Product
7.6.3 Italy Epigenetics Market by End User
7.7 Rest of Europe Epigenetics Market
7.7.1 Rest of Europe Epigenetics Market by Application
7.7.2 Rest of Europe Epigenetics Market by Product
7.7.3 Rest of Europe Epigenetics Market by End User
Chapter 8. Company Profiles
8.1 Abcam plc
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.2 Agilent Technologies, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Acquisition and Mergers:
8.3 Hologic, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Illumina, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 Merck Group (Merck Millipore)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.6 PerkinElmer, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.5.3 Acquisition and Mergers:
8.7 Qiagen N.V.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Thermo Fisher Scientific, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Zymo Research
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.10. Active Motif, Inc.
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
8.10.2.2 Acquisition and Mergers:
TABLE 1 Europe Epigenetics Market, 2018 - 2021, USD Million
TABLE 2 Europe Epigenetics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements – Epigenetics Market
TABLE 4 Product Launches And Product Expansions – Epigenetics Market
TABLE 5 Acquisition and Mergers – Epigenetics Market
TABLE 6 Europe Epigenetics Market by Application, 2018 - 2021, USD Million
TABLE 7 Europe Epigenetics Market by Application, 2022 - 2028, USD Million
TABLE 8 Europe Oncology Market by Country, 2018 - 2021, USD Million
TABLE 9 Europe Oncology Market by Country, 2022 - 2028, USD Million
TABLE 10 Europe NON-ONCOLOGY Market by Country, 2018 - 2021, USD Million
TABLE 11 Europe Non Oncology Market by Country, 2022 - 2028, USD Million
TABLE 12 Europe Epigenetics Market by Product, 2018 - 2021, USD Million
TABLE 13 Europe Epigenetics Market by Product, 2022 - 2028, USD Million
TABLE 14 Europe Kits Market by Country, 2018 - 2021, USD Million
TABLE 15 Europe Kits Market by Country, 2022 - 2028, USD Million
TABLE 16 Europe Reagents Market by Country, 2018 - 2021, USD Million
TABLE 17 Europe Reagents Market by Country, 2022 - 2028, USD Million
TABLE 18 Europe Enzymes Market by Country, 2018 - 2021, USD Million
TABLE 19 Europe Enzymes Market by Country, 2022 - 2028, USD Million
TABLE 20 Europe Instruments Market by Country, 2018 - 2021, USD Million
TABLE 21 Europe Instruments Market by Country, 2022 - 2028, USD Million
TABLE 22 Europe Epigenetics Market by End User, 2018 - 2021, USD Million
TABLE 23 Europe Epigenetics Market by End User, 2022 - 2028, USD Million
TABLE 24 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 25 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 26 Europe Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 27 Europe Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 28 Europe Contract Research Organizations Market by Country, 2018 - 2021, USD Million
TABLE 29 Europe Contract Research Organizations Market by Country, 2022 - 2028, USD Million
TABLE 30 Europe Epigenetics Market by Country, 2018 - 2021, USD Million
TABLE 31 Europe Epigenetics Market by Country, 2022 - 2028, USD Million
TABLE 32 Germany Epigenetics Market, 2018 - 2021, USD Million
TABLE 33 Germany Epigenetics Market, 2022 - 2028, USD Million
TABLE 34 Germany Epigenetics Market by Application, 2018 - 2021, USD Million
TABLE 35 Germany Epigenetics Market by Application, 2022 - 2028, USD Million
TABLE 36 Germany Epigenetics Market by Product, 2018 - 2021, USD Million
TABLE 37 Germany Epigenetics Market by Product, 2022 - 2028, USD Million
TABLE 38 Germany Epigenetics Market by End User, 2018 - 2021, USD Million
TABLE 39 Germany Epigenetics Market by End User, 2022 - 2028, USD Million
TABLE 40 UK Epigenetics Market, 2018 - 2021, USD Million
TABLE 41 UK Epigenetics Market, 2022 - 2028, USD Million
TABLE 42 UK Epigenetics Market by Application, 2018 - 2021, USD Million
TABLE 43 UK Epigenetics Market by Application, 2022 - 2028, USD Million
TABLE 44 UK Epigenetics Market by Product, 2018 - 2021, USD Million
TABLE 45 UK Epigenetics Market by Product, 2022 - 2028, USD Million
TABLE 46 UK Epigenetics Market by End User, 2018 - 2021, USD Million
TABLE 47 UK Epigenetics Market by End User, 2022 - 2028, USD Million
TABLE 48 France Epigenetics Market, 2018 - 2021, USD Million
TABLE 49 France Epigenetics Market, 2022 - 2028, USD Million
TABLE 50 France Epigenetics Market by Application, 2018 - 2021, USD Million
TABLE 51 France Epigenetics Market by Application, 2022 - 2028, USD Million
TABLE 52 France Epigenetics Market by Product, 2018 - 2021, USD Million
TABLE 53 France Epigenetics Market by Product, 2022 - 2028, USD Million
TABLE 54 France Epigenetics Market by End User, 2018 - 2021, USD Million
TABLE 55 France Epigenetics Market by End User, 2022 - 2028, USD Million
TABLE 56 Russia Epigenetics Market, 2018 - 2021, USD Million
TABLE 57 Russia Epigenetics Market, 2022 - 2028, USD Million
TABLE 58 Russia Epigenetics Market by Application, 2018 - 2021, USD Million
TABLE 59 Russia Epigenetics Market by Application, 2022 - 2028, USD Million
TABLE 60 Russia Epigenetics Market by Product, 2018 - 2021, USD Million
TABLE 61 Russia Epigenetics Market by Product, 2022 - 2028, USD Million
TABLE 62 Russia Epigenetics Market by End User, 2018 - 2021, USD Million
TABLE 63 Russia Epigenetics Market by End User, 2022 - 2028, USD Million
TABLE 64 Spain Epigenetics Market, 2018 - 2021, USD Million
TABLE 65 Spain Epigenetics Market, 2022 - 2028, USD Million
TABLE 66 Spain Epigenetics Market by Application, 2018 - 2021, USD Million
TABLE 67 Spain Epigenetics Market by Application, 2022 - 2028, USD Million
TABLE 68 Spain Epigenetics Market by Product, 2018 - 2021, USD Million
TABLE 69 Spain Epigenetics Market by Product, 2022 - 2028, USD Million
TABLE 70 Spain Epigenetics Market by End User, 2018 - 2021, USD Million
TABLE 71 Spain Epigenetics Market by End User, 2022 - 2028, USD Million
TABLE 72 Italy Epigenetics Market, 2018 - 2021, USD Million
TABLE 73 Italy Epigenetics Market, 2022 - 2028, USD Million
TABLE 74 Italy Epigenetics Market by Application, 2018 - 2021, USD Million
TABLE 75 Italy Epigenetics Market by Application, 2022 - 2028, USD Million
TABLE 76 Italy Epigenetics Market by Product, 2018 - 2021, USD Million
TABLE 77 Italy Epigenetics Market by Product, 2022 - 2028, USD Million
TABLE 78 Italy Epigenetics Market by End User, 2018 - 2021, USD Million
TABLE 79 Italy Epigenetics Market by End User, 2022 - 2028, USD Million
TABLE 80 Rest of Europe Epigenetics Market, 2018 - 2021, USD Million
TABLE 81 Rest of Europe Epigenetics Market, 2022 - 2028, USD Million
TABLE 82 Rest of Europe Epigenetics Market by Application, 2018 - 2021, USD Million
TABLE 83 Rest of Europe Epigenetics Market by Application, 2022 - 2028, USD Million
TABLE 84 Rest of Europe Epigenetics Market by Product, 2018 - 2021, USD Million
TABLE 85 Rest of Europe Epigenetics Market by Product, 2022 - 2028, USD Million
TABLE 86 Rest of Europe Epigenetics Market by End User, 2018 - 2021, USD Million
TABLE 87 Rest of Europe Epigenetics Market by End User, 2022 - 2028, USD Million
TABLE 88 key information – Abcam plc
TABLE 89 key Information – Agilent Technologies, Inc.
TABLE 90 Key information – Hologic, Inc.
TABLE 91 key information – Illumina, Inc.
TABLE 92 key Information – Merck GrouP
TABLE 93 key Information – PerkinElmer, Inc.
TABLE 94 Key Information – Qiagen N.V.
TABLE 95 Key Information – Thermo Fisher Scientific, Inc.
TABLE 96 Key Information – Zymo Research
TABLE 97 Key Information – Active Motif, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2018, Apr – 2021, Dec) Leading Players
FIG 5 Recent strategies and developments: PerkinElmer, Inc.
FIG 6 Recent strategies and developments: Active Motif, Inc.